ARCHIVES

Aranesp Improved Anemia In MDS In Phase II Trial

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Stops Imports Of Counterfeit Adriamychin; Rosenburg: NIH Pay 25-33% That Of Academia

April 22, 1988

Bosnian Research Trying To Leave, Asks For More Calls

February 5, 1993

Preliminary Action Plan Seeks Consumer Representation

January 7, 1994

Hormonal Therapy Improves Prostate Cancer Survival

August 27, 2004

“Wild West” of Molecular Testing?: Caris Engaged in Aggressive Marketing, Improper Medicare Billing, Lawsuit Alleges

August 8, 2014

Specter Remains Chairman Of Labor-HHS Subcommittee.

February 2, 2001